Cost-Effectiveness of Genotype-Guided and Dual Antiplatelet Therapies

被引：0
|
作者：
Marciniak, Thomas A. [1 ]
机构：
[1] US FDA, Silver Spring, MD 20993 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2014年 / 161卷 / 05期
关键词：
D O I：
10.7326/L14-5017-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：378 / 378
页数：1
相关论文
共 50 条
  • [1] Cost-Effectiveness of Genotype-Guided and Dual Antiplatelet Therapies in Acute Coronary Syndrome
    Kazi, Dhruv S.
    Garber, Alan M.
    Shah, Rashmee U.
    Dudley, R. Adams
    Mell, Matthew W.
    Rhee, Ceron
    Moshkevich, Solomon
    Boothroyd, Derek B.
    Owens, Douglas K.
    Hlatky, Mark A.
    [J]. ANNALS OF INTERNAL MEDICINE, 2014, 160 (04) : 221 - 232
  • [2] Genotype-guided antiplatelet therapy with platelet reactivity testing: A cost-effectiveness analysis
    Jiang, Minghuan
    You, Joyce
    [J]. PHARMACOTHERAPY, 2015, 35 (11): : E206 - E206
  • [3] COST-EFFECTIVENESS OF CYP2C19 GENOTYPE-GUIDED DUAL ANTIPLATELET THERAPY FOR ACUTE MINOR ISCHEMIC STROKE OR TIA
    Kremers, F.
    Venema, E.
    Cras, T.
    Burke, J.
    Roozenbeek, B.
    Dippel, D.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2021, 16 (2_SUPPL) : 19 - 19
  • [4] COST-EFFECTIVENESS EVALUATION OF GENOTYPE-GUIDED ANTIPLATELET THERAPY VERSUS UNIVERSAL NEW ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME
    Jiang, M.
    You, J.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A20 - A20
  • [5] THE COST-EFFECTIVENESS OF GENOTYPE-GUIDED WARFARIN DOSING FOR PATIENTS WITH ATRIAL FIBRILLATION
    Patrick, A.
    Avorn, J.
    Choudhry, N. K.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 : 181 - 181
  • [6] Cost-effectiveness of antiplatelet therapies
    Schleinitz, MD
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (09) : 1236 - 1236
  • [7] Cost-Effectiveness of Genotype-Guided Warfarin Dosing for Patients With Atrial Fibrillation
    Patrick, Amanda R.
    Avorn, Jerry
    Choudhry, Niteesh K.
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2009, 2 (05): : 429 - U51
  • [8] The Cost-Effectiveness of Genotype-Guided Warfarin Dosing for Patients with Atrial Fibrillation
    Patrick, Amanda R.
    Avorn, Jerry
    Choudhry, Niteesh K.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S23 - S24
  • [9] Cost-effectiveness of genotype-guided aspirin use for colorectal cancer prevention.
    Biltaji, Eman
    Au, Trang H.
    Walker, Brandon
    Ose, Jennifer
    Ulrich, Cornelia M.
    Stenehjem, David D.
    Brixner, Diana I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] Give genotype-guided dual antiplatelet therapy a second CHANCE
    Liuzzo, Giovanna
    Patrono, Carlo
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 (10) : 938 - 939
12345